Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01593462 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of MR Enterography

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01593462: Completed NA study, sponsored by University of Michigan.

NCT01593462 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01593462, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to determine the efficacy of ultrasound imaging compared to MRE (Magnetic Resonance Enterography) a form of magnetic resonance imaging (MRI) in accurately diagnosing and following Small Bowel Crohn Disease (SBCD) in children.

Primary Outcome

To assess accuracy in imaging techniques

Interventions

  • PROCEDURE MRE (magnetic resonance enterography)
  • PROCEDURE The Ultrasound scan, (UEI) Ultrasound Elastography Imaging with ARFI (acoustic radiation force impulse)
  • BEHAVIORAL Study Questionnaires

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2011-05
Est. Completion 2016-12
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01593462 record still lists

NCT01593462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which MRE (magnetic resonance enterography) is the first listed.

NCT01593462 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01593462 about?

NCT01593462 is a clinical study titled "Comparative Effectiveness of MR Enterography". The purpose of this study is to determine the efficacy of ultrasound imaging compared to MRE (Magnetic Resonance Enterography) a form of magnetic resonance imaging (MRI) in accurately diagnosing and following Small Bowel Crohn Disease (SBCD) in children.

What is the current status of trial NCT01593462?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-05. Estimated completion is 2016-12.

What interventions are being tested in trial NCT01593462?

The interventions under investigation include: MRE (magnetic resonance enterography) (PROCEDURE), The Ultrasound scan, (UEI) Ultrasound Elastography Imaging with ARFI (acoustic radiation force impulse) (PROCEDURE), Study Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT01593462?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01593462's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01593462, the US trial registry maintained by the National Library of Medicine. NCT01593462 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.